17Dec
Related Posts
25Mar
Encouraging results for Immutep’s cancer therapies
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.
Read More
06Aug
Copper-gold in Utah and lithium in Brazil
06 Aug 2024 - Alderan Resources Limited (ASX:AD8) Managing Director Scott Caithness discusses the company's exploration targets and progress.
Read More
17Jun
From Challenger to Revolution
17 June 2025 - How Bob Sahota turned a defensive credit philosophy into one of Australia’s most respected private debt funds.
Read More
22Jul
icetana (ASX:ICE) quarterly investor update, July 2021
21 Jul 2021 - icetana (ASX:ICE) CEO and Managing Director Matt Macfarlane provides an update for the June quarter 2021.
Read More
24Feb
Market update with Shaw and Partners, February 2022
24 Feb 2022 - Shaw and Partners Chief Investment Officer Martin Crabb discusses the sectors to invest in given slowing global growth, tightening financial conditions, the risk of inflation and geopolitical imbalances.
Read More
30Jul
Fed policy, tech stocks and small caps: A discussion with Jeffrey Schulze
30 Jul 2024 - Jeffrey Schulze, Managing Director of ClearBridge Investments, shares insights on the US markets, discussing interest rates, catalysts for the rotation out of tech and the Magnificent Seven and the durability of the move into small caps.
Read More
18May
Chimeric Therapeutics (ASX:CHM) expands cancer trials
18 May 2022 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow provides an update on clinical trial progression, and discusses recent agreements with WuXi Advanced Therapies and Be The Match BioTherapies.
Read More
09Mar
Knosys (ASX:KNO) discusses 1H FY23 results
09 March 2023 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses drivers of revenue growth, the roadmap for the company's three SaaS solutions, onshoring GreenOrbit operations and outlook for the second half.
Read More
17May
QX Resources (ASX:QXR) announces letter of intent with Liberty Lithium
17 May 2023 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses the company's letter of intent with Liberty Lithium, the advantages of the project, the difference between brine and hard rock lithium, and the timeline ahead.
Read More
10Mar
Global market reaction on Ukraine crisis, inflation & commodities
10 Mar 2022 - Blair Kirkhope, Head of Specialist Investments at Sequoia Financial Group (ASX:SEQ), discusses trends in investment markets, inflation, and asset classes and sectors to watch.
Read More